Last reviewed · How we verify

NCT04663490

Neutrophil to Lymphocyte Ratio as a Predictor of Complicated Acute Diverticulitis

Completed Last updated 11 December 2020
What this trial tests

trial testing Neutrophil to Lymphocyte Ratio in Acute Diverticulitis in 325 participants. Completed in 1 January 2020.

Timeline
1 January 2013
Primary endpoint
1 January 2018
1 January 2020

Quick facts

Lead sponsorClinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba
StatusCompleted
Study typeOBSERVATIONAL
Enrollment325
Start date1 January 2013
Primary completion1 January 2018
Estimated completion1 January 2020
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba

Who can join

Adults 18 to 92, any sex, with Acute Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Various biomarkers have been studied to predict the severity of acute diverticulitis (AD), such as the leukocyte count and CRP, which are useful but lack sufficient sensitivity. The neutrophil-lymphocyte ratio (NLR) has been identified as a new inflammatory biomarker in several abdominal pathologies. However, few studies determine its association with the severity of AD. The objective of the present study was to determine the utility and diagnostic precision of NLR in complicated acute diverticulitis (cAD). Material and methods: Descriptive, retrospective and analytical study. Patients older than 18 years with a diagnosis of AD were included, from 2013 - 2018. Demographic variables, days of hospitalization, leukocyte count, neutrophils, lymphocytes, ESR, CRP, and NLR were analyzed. The sensitivity and specificity for the diagnosis of cAD were determined using ROC curves.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Neutrophil-to-lymphocyte ratio as a predictor of complicated acute diverticulitis: A retrospective cohort study.
    Palacios Huatuco RM, Pantoja Pachajoa DA, Bruera N, Pinsak AE, et al · · 2021 · cited 10× · PMID 33643646 · DOI 10.1016/j.amsu.2021.01.076

Verify or expand the search:

Other Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing